The conditions by which the production, in liquid media, of hemolytic activity by growing cells of T. hyodysenteriae and T. innocens are described. / From a ribonucleic acid added culture broth of T. hyodysenteriae, two hemolysins are shown in the supernatant. For each of them, a purification scheme allowing the obtention of an homogeneous hemolytic preparation by gel filtration and electrophoresis, is proposed. One hemolysin is associated with ribonucleic acid (HN) while the later is associated with bovine serum albumin (HP). They share some properties: their synthesis is blocked by chloramphenicol, they do not have proteolytic or phospholipasic activities, they are insensitive to oxygen and their activity does not require bivalent cations or is sensitive to EDTA's action; they are lytic to all red blood cell's type tested. They differ by the size of their apparent molecular weight, their mode of action, the stability of their activity to temperature and different pH and, their pattern of sensitivity to proteolytic enzymes. / The isolation of a non-hemolytic mutant strain of T. hyodysenteriae and its use in a ligated ileal loop model in rabbit has shown that there is a relation between the loss of the hemolytic activity and the loss of the enterotoxic activity.

No description available.

Wong, Sze Ki. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 87-106). / Abstracts in English and Chinese. / Acknowledgements --- p.i / Abstract --- p.ii / Abstract in Chinese --- p.iv / Table of contents --- p.V / List of figures --- p.ix / List of abbreviations --- p.X / Chapter Chapter 1. --- General introduction --- p.1 / Chapter Chapter 2. --- Literature review --- p.6 / Chapter 2.1. --- Pathogenic mechanisms of Vibrio species in fish --- p.7 / Chapter 2.1.1. --- Introduction --- p.7 / Chapter 2.1.2. --- Adhesion --- p.7 / Chapter 2.1.3. --- Invasion --- p.8 / Chapter 2.1.4. --- Proliferation --- p.9 / Chapter 2.2. --- Vibrio virulence factors --- p.12 / Chapter 2.2.1. --- Introduction --- p.12 / Chapter 2.2.2. --- Hemolysin --- p.12 / Chapter 2.2.3. --- Protease --- p.14 / Chapter 2.2.4. --- Siderophore --- p.15 / Chapter 2.2.5. --- Lipopolysaccharide --- p.15 / Chapter 2.3. --- General apoptotic pathways --- p.17 / Chapter 2.3.1. --- Introduction --- p.17 / Chapter 2.3.2. --- Extrinsic apoptotic pathway --- p.17 / Chapter 2.3.2.1. --- Death receptor signaling apoptosis --- p.17 / Chapter 2.3.2.1.1. --- Fas signaling pathway --- p.18 / Chapter 2.3.2.1.2. --- TNF-R1 signaling pathway --- p.19 / Chapter 2.3.2.1.3. --- TRAIL receptors signaling pathway --- p.20 / Chapter 2.3.2.2. --- Growth factor receptor signaling apoptosis --- p.21 / Chapter 2.3.3. --- Intrinsic apoptotic pathway --- p.21 / Chapter 2.3.3.1. --- Mitochondrial apoptotic pathway --- p.21 / Chapter 2.3.3.1.1. --- Cyto c --- p.22 / Chapter 2.3.3.1.2. --- Smac/DIABLO --- p.22 / Chapter 2.3.3.1.3. --- Omi/HtrA2 --- p.22 / Chapter 2.3.3.1.4. --- AIF and endo G --- p.23 / Chapter 2.3.3.1.5. --- Bcl-2 family --- p.23 / Chapter 2.3.3.1.6. --- Mitochondrial membrane permeabilization (MMP) --- p.23 / Chapter 2.3.3.2. --- p53-regulated apoptotic pathway --- p.24 / Chapter 2.3.3.3. --- Endoplasmic reticulum (ER) stress-induced apoptotic pathway --- p.25 / Chapter 2.4. --- Membrane vesiculation in erythrocytes --- p.26 / Chapter 2.4.1. --- Introduction --- p.26 / Chapter 2.4.2. --- Induction of vesiculation --- p.26 / Chapter 2.4.3. --- Contents of vesicles --- p.28 / Chapter 2.4.4. --- Mechanisms involved during vesiculation --- p.29 / Chapter 2.4.5. --- Correlation between apoptosis and membrane vesiculation in erythrocytes --- p.31 / Chapter 2.4.6. --- Reasons for vesiculation --- p.31 / Chapter Chapter 3. --- "Induction of apoptosis by Vibrio alginolyticus thermolabile hemolysin (TLH) in blood cells of silver sea bream, Sparus sarba" --- p.33 / Chapter 3.1. --- Abstract --- p.34 / Chapter 3.2. --- Introduction --- p.34 / Chapter 3.3. --- Materials and methods --- p.36 / Chapter 3.3.1. --- Experimental fish --- p.36 / Chapter 3.3.2. --- Whole blood preparation --- p.37 / Chapter 3.3.3. --- Preparation of V. alginolyticus TLH --- p.37 / Chapter 3.3.4. --- "Caspase-3, -8, -9/6 fluorescent assay" --- p.38 / Chapter 3.3.5. --- TUNEL assay --- p.39 / Chapter 3.3.6. --- Apoptotic DNA ladder assay --- p.40 / Chapter 3.3.7. --- Statistical analysis --- p.41 / Chapter 3.4. --- Results --- p.42 / Chapter 3.4.1. --- "Increase of caspase-3, -8, -9/6 activities" --- p.42 / Chapter 3.4.2. --- Detection of DNA fragmentation by TUNEL assay --- p.44 / Chapter 3.4.3. --- Detection of DNA fragmentation by apoptotic DNA ladder assay --- p.44 / Chapter 3.5. --- Discussion --- p.46 / Chapter Chapter 4. --- "Occurrence of membrane vesiculation, apoptosis and post-apoptotic necrosis after exposure to Vibrio alginolyticus thermolabile hemolysin (TLH) in erythrocytes of silver sea bream, Sparus sarba" --- p.51 / Chapter 4.1. --- Abstract --- p.52 / Chapter 4.2. --- Introduction --- p.52 / Chapter 4.3. --- Materials and methods --- p.54 / Chapter 4.3.1. --- Experimental fish --- p.54 / Chapter 4.3.2. --- Whole blood preparation --- p.54 / Chapter 4.3.3. --- Preparation of V. alginolyticus TLH --- p.55 / Chapter 4.3.4. --- Light microscopy --- p.55 / Chapter 4.3.5. --- Transmission electron microscopy (TEM) --- p.56 / Chapter 4.3.6. --- Measurement of membrane vesiculation - acetylcholinesterase (AChE) assay --- p.56 / Chapter 4.3.7. --- Measurement of necrosis - hemoglobin colorimetric assay --- p.57 / Chapter 4.3.8. --- Apoptotic DNA ladder assay --- p.58 / Chapter 4.3.9. --- Flow cytometry --- p.59 / Chapter 4.3.10. --- Statistical analysis --- p.59 / Chapter 4.4. --- Results --- p.60 / Chapter 4.4.1. --- Ultrastructural changes in red blood cells after exposure to TLH --- p.60 / Chapter 4.4.2. --- Changes of cell population in size and granularity after exposure of TLH --- p.67 / Chapter 4.4.3. --- Effect of TLH dosage on necrosis and DNA fragmentation --- p.72 / Chapter 4.4.4. --- "Occurrence of membrane vesiculation, necrosis and DNA fragmentation in cells exposed to TLH" --- p.72 / Chapter 4.5. --- Discussion --- p.76 / Chapter Chapter 5. --- General conclusions --- p.82 / References --- p.87

Leung, Ho Wai. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2007. / Includes bibliographical references (leaves 136-146). / Abstracts in English and Chinese. / THESIS COMMITTEE --- p.II / ACKNOWLEDGEMENT --- p.III / ABSTRACT --- p.IV / CHINESE ABSTRACT --- p.VI / TABLE OF CONTENT --- p.VII / OVERVIEW OF THIS PROJECT --- p.1 / Chapter SECTION 1: --- Purification and Characterization of hemagglutinins from French bean and mottled kidney bean / Chapter Chapter 1 --- INTRODUCTION / Chapter 1.1 --- General Introduction --- p.2 / Chapter 1.2 --- Physiological functions of plant lectins --- p.6 / Chapter 1.3 --- Physiological functions of animal lectins --- p.9 / Chapter 1.4 --- Biological functions of lectins --- p.12 / Chapter 1.5 --- Clinical and research applications of lectins --- p.16 / Chapter 1.6 --- Legume lectins --- p.17 / Chapter 1.7 --- Isolation and purification of lectins --- p.19 / Chapter 1.8 --- Objectives of the present study --- p.21 / Chapter Chapter 2 --- MATERIALS AND METHODS / Chapter 2.1 --- Chemicals --- p.22 / Chapter 2.2 --- Assay of hemagglutinating activity --- p.24 / Chapter 2.3 --- Purification protocol --- p.26 / Chapter 2.4 --- Assay of saccharide inhibition of hemagglutination --- p.28 / Chapter 2.5 --- Assay of pH stability --- p.28 / Chapter 2.6 --- Molecular mass determination and N-terminal sequence determination --- p.28 / Chapter 2.7 --- Assay of mitogenic activity --- p.29 / Chapter 2.8 --- Assay of antiproliferative activity --- p.30 / Chapter 2.9 --- Assay for antifungal activity --- p.30 / Chapter 2.10 --- Assay of HIV-1 reverse transcriptase inhibitory activity --- p.31 / Chapter 2.11 --- Assay of stability towards trypsin and chymotrypsin --- p.31 / Chapter 2.12 --- Assay of nitric oxide production --- p.32 / Chapter 2.13 --- Assay ofHIV-1 integrase --- p.32 / Chapter Chapter 3 --- EXPERIMENTAL RESULTS / Chapter 3.1 --- Purification scheme --- p.35 / Chapter 3.2 --- Size determination and N-terminal sequencing --- p.36 / Chapter 3.3 --- Temperature stability assay --- p.37 / Chapter 3.4 --- pH stability assay --- p.37 / Chapter 3.5 --- Saccharides inhibition of hemagglutination --- p.37 / Chapter 3.6 --- Stability towards Trypsin and Chymotrypsin --- p.38 / Chapter 3.7 --- Anti-proliferative activity --- p.38 / Chapter 3.8 --- HTV-1 reverse transcriptase inhibition --- p.39 / Chapter 3.9 --- Mitogenic activity --- p.39 / Chapter 3.10 --- Nitric oxide production --- p.39 / Chapter 3.11 --- HIV-1 integrase --- p.39 / Chapter 3.12 --- Defensin --- p.40 / Chapter Chapter 4 --- DISCUSSION / Chapter 4.1 --- Purification scheme --- p.68 / Chapter 4.2 --- Sequence comparison --- p.69 / Chapter 4.3 --- Physical Stability of the hemagglutinins --- p.70 / Chapter 4.4 --- Protease Stability --- p.71 / Chapter 4.5 --- Sugar Specificity Assay --- p.72 / Chapter 4.6 --- Anti-proliferative Aactivity toward Cancer Cells --- p.73 / Chapter 4.7 --- HTV-1 reverse trancriptase and H̐ơþV integrase inhibition --- p.74 / Chapter 4.8 --- Mitogenic activity --- p.75 / Chapter 4.9 --- Antifungal protein --- p.76 / Chapter Chapter 5 --- CONCLUSION --- p.78 / Chapter SECTION 2: --- Purification and Characterization of flammulolysin from mushroom Flαmmulinα velutipes / Chapter Chapter 1 --- INTRODUCTION / Chapter 1.1 --- General Introduction --- p.79 / Chapter 1.2 --- Mechanisms of hemolysis --- p.80 / Chapter 1.3 --- Biological role of hemolysins --- p.80 / Chapter 1.4 --- Mushroom hemolysin --- p.82 / Chapter 1.5 --- Applications of hemolysins --- p.83 / Chapter 1.6 --- Objectives of the present study --- p.83 / Chapter Chapter 2 --- MATERIALS AND METHODS --- p.84 / Chapter Chapter 3 --- EXPERIMENTAL RESULTS / Chapter 3.1 --- Purification and sequence determination --- p.90 / Chapter 3.2 --- Effect of sugars and salts on hemolysin --- p.90 / Chapter 3.3 --- Effect of Temperature and pH on hemolysin --- p.91 / Chapter 3.4 --- Effect of Proteases on hemolysin --- p.91 / Chapter 3.5 --- Effect of osmotic protection on hemolysin --- p.91 / Chapter 3.6 --- Effect of hemolysin on tumor cells --- p.91 / Chapter 3.7 --- Effect of hemolysin on spleen cells --- p.92 / Chapter 3.8 --- Effect of hemolysin on bacterial growth --- p.92 / Chapter 3.9 --- Effect of hemolysin on fungal growth --- p.92 / Chapter Chapter 4 --- DISCUSSION / Chapter 4.1 --- Purification and sequence comparison of hemolysin --- p.103 / Chapter 4.2 --- Sugar and Salts inhibition --- p.104 / Chapter 4.3 --- Temperature stability --- p.105 / Chapter 4.4 --- pH stability --- p.106 / Chapter 4.5 --- Protease stability --- p.106 / Chapter 4.6 --- Osmotic Protection --- p.106 / Chapter 4.7 --- Anti-tumour activity of the hemolysin --- p.107 / Chapter 4.8 --- Anti-fungal activity --- p.108 / Chapter Chapter 5 --- CONCLUSION --- p.109 / Chapter SECTION 3: --- Purification and Characterization of antifungal peptide from buckwheat seeds Fagopyrum esculentum / Chapter Chapter 1 --- INTRODUCTION / Chapter 1.1 --- Plant antiftmgal proteins --- p.110 / Chapter 1.2 --- Classification of antifungal proteins --- p.110 / Chapter 1.3 --- Distribution of antifungal proteins in plants --- p.111 / Chapter 1.4 --- Mechanisms of antifungal activity --- p.111 / Chapter 1.5 --- Future Perspectives of Antifungal proteins --- p.112 / Chapter 1.6 --- Antifungal peptide from Buckwheat --- p.112 / Chapter 1 .7 --- Objectives of the present study --- p.113 / Chapter Chapter 2 --- MATERIALS AND METHODS --- p.114 / Chapter Chapter 3 --- EXPERIMENTAL RESULTS / Chapter 3.1 --- Purification and sequence determination --- p.118 / Chapter 3.2 --- Effect on anti-fungal activity --- p.118 / Chapter 3.3 --- Effect of temperature and pH on antifungal activity --- p.118 / Chapter 3.4 --- Effect of the antifungal peptide on tumor cells --- p.119 / Chapter 3.5 --- Effect of antifungal peptide on HIV-1 Reverse transcriptase Activity --- p.119 / Chapter 3.6 --- Effect of antifungal peptide on spleen cells and NO Production --- p.119 / Chapter Chapter 4 --- DISCUSSION / Chapter 4.1 --- Purification scheme and N-terminal sequence --- p.130 / Chapter 4.2 --- Antifungal Activity --- p.131 / Chapter 4.3 --- Physical stability --- p.131 / Chapter 4.4 --- Anti-proliferative activity toward cancer cells --- p.131 / Chapter 4.5 --- HTV-1 Reverse Transcriptase Inhibitory activity --- p.132 / Chapter 4.6 --- Mitogenic activity and nitric oxide production --- p.132 / Chapter Chapter 5 --- CONCLUSION --- p.133 / OVERALL CONCLUSION --- p.134 / REFERENCES --- p.136

Orientador: Joelcio Francisco Abbade / Banca: José Carlos Peraçoli / Banca: Francisco Lázaro Pereira de Souza / Resumo: INTRODUÇÃO: A síndrome HELLP é uma complicação severa da pré-eclâmpsia, caracterizada por hemólise, elevação das enzimas hepáticas e trombocitopenia. Apesar de haver padronização dos valores laboratoriais que definem a síndrome HELLP, ainda existe dificuldade para a caracterização da hemólise. OBJETIVO: Avaliar o valor de haptoglobina que determina a hemólise nas pacientes com síndrome HELLP. MÉTODOS: estudo transversal e prospectivo de gestantes e puérperas com de pré-eclâmpsia. Exame laboratorial avaliado: dosagem sérica de haptoglobina. Construção da curva ROC para determinar o valor de corte da haptoglobina para diagnóstico de hemólise na síndrome HELLP. RESULTADOS: O valor da haptoglobina para diagnóstico de hemólise em pacientes com síndrome HELLP foi de 0,26g/L. DISCUSSÃO: A melhor correlação observada foi a haptoglobina com a DHL, indicando que este é o melhor marcador de hemólise intravascular para o diagnóstico da síndrome HELLP. CONCLUSÃO: A dosagem sérica da haptoglobina nos casos de pré-eclâmpsia deve fazer parte dos exames de rotina para diagnóstico de hemólise intravascular da síndrome HELLP / Abstract: CONTEXT: HELLP syndrome is a severe complication of pre-eclampsia, caracterized by hemolysis, elevated liver enzymes and low platelet count. Although there are standardized laboratory values that define the HELLP syndrome, the difficulty still exists for the characterization of hemolysis. PURPOSE: to evaluate the haptoglobin value to diagnose the hemolysis in HELLP syndrome. METHODS: transversal and prospective study of pregnant and postdelivery women with pre-eclampsia. Laboratory tests evaluated: serum haptoglobin. ROC curve to determine the cutoff value of haptoglobin in the diagnosis of hemolysis in HELLP syndrome. RESULTS: The haptoglobin value for hemolysis diagnosis in HELLP syndrome was 0.26 g / L. DISCUSSION: The best correlation was with haptoglobin and DHL, indicating that this is the best marker of intravascular hemolysis for the diagnosis of HELLP syndrome. CONCLUSION: Serum haptoglobin in cases of pre-eclampsia should be part of routine tests for diagnosis of intravascular hemolysis in HELLP syndrome / Mestre

Includes an appendix of author's previously published papers. / Bibliography: leaves 123-160. / 160, [105] leaves, [30] leaves of plates : ill. ; 30 cm. / Title page, contents and abstract only. The complete thesis in print form is available from the University Library. / Thesis (Ph.D.)--University of Adelaide, Dept. of Microbiology and Immunology, 1990

Made available in DSpace on 2015-01-26T13:21:21Z (GMT). No. of bitstreams: 0 Previous issue date: 2014-08-08Bitstream added on 2015-01-26T13:30:38Z : No. of bitstreams: 1 000797817.pdf: 449554 bytes, checksum: 7adc756b2ac04e5d1cbc6be34fa7a04e (MD5) / Introdução: A síndrome HELLP é uma complicação severa da pré-eclâmpsia, caracterizada por hemólise, elevação das enzimas hepáticas e trombocitopenia. Apesar de haver padronização dos valores laboratoriais que definem a síndrome HELLP, ainda existe dificuldade para a caracterização da hemólise. OBJETIVO: Avaliar o valor de haptoglobina que determina a hemólise nas pacientes com síndrome HELLP. MÉTODOS: estudo transversal e prospectivo de gestantes e puérperas com de pré-eclâmpsia. Exame laboratorial avaliado: dosagem sérica de haptoglobina. Construção da curva ROC para determinar o valor de corte da haptoglobina para diagnóstico de hemólise na síndrome HELLP. RESULTADOS: O valor da haptoglobina para diagnóstico de hemólise em pacientes com síndrome HELLP foi de 0,26g/L. DISCUSSÃO: A melhor correlação observada foi a haptoglobina com a DHL, indicando que este é o melhor marcador de hemólise intravascular para o diagnóstico da síndrome HELLP. CONCLUSÃO: A dosagem sérica da haptoglobina nos casos de pré-eclâmpsia deve fazer parte dos exames de rotina para diagnóstico de hemólise intravascular da síndrome HELLP / Context: HELLP syndrome is a severe complication of pre-eclampsia, caracterized by hemolysis, elevated liver enzymes and low platelet count. Although there are standardized laboratory values that define the HELLP syndrome, the difficulty still exists for the characterization of hemolysis. PURPOSE: to evaluate the haptoglobin value to diagnose the hemolysis in HELLP syndrome. METHODS: transversal and prospective study of pregnant and postdelivery women with pre-eclampsia. Laboratory tests evaluated: serum haptoglobin. ROC curve to determine the cutoff value of haptoglobin in the diagnosis of hemolysis in HELLP syndrome. RESULTS: The haptoglobin value for hemolysis diagnosis in HELLP syndrome was 0.26 g / L. DISCUSSION: The best correlation was with haptoglobin and DHL, indicating that this is the best marker of intravascular hemolysis for the diagnosis of HELLP syndrome. CONCLUSION: Serum haptoglobin in cases of pre-eclampsia should be part of routine tests for diagnosis of intravascular hemolysis in HELLP syndrome

Orientador: Tomomassa Yano / Dissertação (mestrado) - Universidade Estadual de Campinas,. Instituto de Biologia / Made available in DSpace on 2018-08-14T11:00:37Z (GMT). No. of bitstreams: 1 Thome_JacquelineDarcSilva_M.pdf: 1223668 bytes, checksum: 17699f260f82fb8a09136004fcc1e28a (MD5) Previous issue date: 2006 / Mestrado / Microbiologia / Mestre em Genética e Biologia Molecular

<i>Actinobacillus pleuropneumoniae</i> is the etiological agent of contagious swine pleuropneumonia, an economically important disease of the swine industry worldwide. Improved control of this disease requires enhanced understanding of the factors contributing to pathogenesis. The objectives of this study were to investigate the immune response and virulence properties of the 110-kilodalton (110-KDa) hemolysins [hemolysin I (HlyI) and hemolysin II (HlyII)] of <i>A. pleuropneumoniae</i>. Several monoclonal antibodies (MAb) to the hemolysins were developed. An IgGl. MAb (8C2) specific for HlyII, as determined by immunoblotting, was cross-linked to Protein A-Sepharose, and HlyII was purified from serotypes 1 and 5 by immunoaffinity chromatography. An indirect enzyme-linked immunosorbent assay (ELISA) using MAb 8C2, or affinitypurified rabbit IgG to both hemolysins, was developed for detection of swine antibody to one or both hemolysins, respectively. In comparison with the complement fixation test, the ELISA was highly sensitive and specific, and was able to identify animals infected with or exposed to most, if not all, serotypes of <i>A. pleuropneumoniae</i>. Several nonhemolytic mutants of <i>A. pleuropneumoniae</i> serotype 5 were isolated following electroporation of the parent with an hemolysin gene whose open-reading-frame was disrupted with a kanamycin resistance gene. One mutant was characterized for phenotypic and pathogenic properties. Biochemical profiles, growth rate, capsule content, and lipopolysaccharide and whole cell protein electrophoretic profiles of the parent and one of the mutants were similar. The nonhemolytic mutant lacked both HlyI and HlyII proteins in culture supernatant and in whole cell lysates as determined by immunoblot analysis; extracellular and intracellular hemolytic and cytotoxic activity was also absent. The mutant was avirulent in mice and pigs at doses greater than 10 times the lethal dose of the parent. Unlike the parent, the nonhemolytic mutant failed to confer protection against lethal challenge in mice following immunization. Thus, one or both hemolysins are essential for virulence and immunoprotection in <i>A. pleuropneumoniae</i> serotype 5. / Ph. D.

The use of hemocomponents from blood group "O" in transfusions among different blood groups may lead to transfusion reactions if the anti-A and anti-B agglutinins, present in the donor s serum / plasma, show high titers scores equal to or higher than 100. The transfusion reactions most reported with antibodies of high titers are caused by platelet concentrate, due to the presence of plasma in this hemocomponent. Considering the small number of studies on the anti-A and anti-B hemolysins and the importance of these antibodies in transfusion practice, the goal of this work was to verify the frequency of these hemolysins and their association to genre and Rh factor in 500 serum samples of type "O" registered donors at the Blood Center of Cruz Alta, RS. The results showed that the frequency of donor blood group "O" considered dangerous was 11.6% (58), and non-dangerous 88.4% (442). There was a predominance between the dangerous 50% (29) to reactive anti-A hemolysin , 37.9% (22) anti-B and 12.1% (7) for agglutinins anti-A and anti-B. Sampling of donors was not homogeneous regarding sex and not the type of blood factor, prevailing men 65% (325), Rh positive. There was no correlation between antibody screening Irregulars (PAI) with regular search antibody anti-A and anti-B. Also there was no assocation betwiin the prevalence in the variables gender, blood Rh factor anti anti-A and anti-B. It was noticed that the anti-A shows reaction under great in comparison with the anti-B thus both react in 100% of cases to1/16 however, the anti-Adecreas its percentage from1/128 whereas anti-B 1/32. The age prevalence of dangerous donors for anti-A was between 33 to 46 years, anti-B from 16 to 25 years and for both antibodies between 25 and 33 years. The results of this research can be used to measure the prevalence of these hemolysins and prevent risks of incompatible transfusion events, since in transfusion practice there is greater availability of group "O" donors and these are not classified as risk-donor "O" yet. Thus, in the search for excellence in transfusion practice and, above all, effectivenessly, it is essential to standardize the Regular Antibodies Research. / O uso de hemocomponentes do grupo sanguíneo O em transfusões nãoisogrupo pode acarretar reações transfusionais, caso as aglutininas anti-A e anti-B presentes no soro/plasma do doador, apresentem títulos elevados com escore igual ou superior a 100. As reações transfusionais mais relatadas com anticorpos de altos títulos são ocasionadas por concentrado de plaquetas, devido à presença de plasma neste hemocomponente. Considerando a pequena quantidade de estudos sobre as hemolisinas anti-A e anti-B e a importância desses anticorpos na prática transfusional, o objetivo deste trabalho foi verificar a freqüência dessas hemolisinas e a associação a gênero e fator Rh em 500 amostras de soros dos doadores tipo O cadastrados no Hemocentro de Cruz Alta,RS. Os resultados mostraram que a freqüência dos doadores de sangue do grupo O considerados perigosos foi de 11,6% (58), e de não-perigosos 88,4% (442). Constatou-se uma predominância entre os perigosos, de 50% (29) reativos para hemolisina anti-A, 37,9% (22) anti-B e 12,1% (7) para aglutininas anti-A e anti-B. A amostragem dos doadores não foi homogênea quanto ao sexo e nem quanto ao tipo de fator sanguíneo, prevalecendo homens 65% (325), Rh positivo 80,4% (402). Não houve correlação entre a Pesquisa de Anticorpos Irregulares (PAI) com a Pesquisa dos Anticorpos Regulares anti-A e anti-B. Também não existiu prevalência na associação entre as variáveis gênero, fator sanguíneo Rh e anticorpo anti-A e anti-B. Percebeu-se que o anticorpo anti-A apresenta título maior de reação em comparação com o anti-B pois, ambos reagem em 100% dos casos até 1/16 porém, anti-A diminui seu percentual de reação a partir de 1/128 enquanto que anti-B em 1/32. A faixa etária de prevalência de doadores perigosos para anti-A foi entre 33 a 46 anos, anti-B entre 16 a 25 anos e para ambos anticorpos entre 25 e 33 anos. Os resultados desta pesquisa podem servir para mensurar a prevalência destas hemolisinas e prevenir riscos de episódios transfusionais incompatíveis, visto que na prática transfusional ocorre maior disponibilidade de doadores do grupo O e estes ainda não são classificados como doadores O perigosos. Assim, na busca pela prática transfusional com excelência e, sobretudo, com eficácia, torna-se imprescindível a padronização da Pesquisa de Anticorpos Regulares.